Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
about
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesisSpecific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell lineDeep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine.Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsLymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancerClinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.Functional roles of human kallikrein-related peptidases.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Detection of Enzyme Activity and Inhibition during Studies in Solution, In Vitro and In Vivo with CatalyCEST MRI.Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp.Identification of novel tumor suppressor proteases by degradome profiling of colorectal carcinomas.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
P2860
Q28397239-19FD4483-5F0F-4F9F-AB0B-647D7AE215E9Q33581581-37AA57B3-69C9-47C9-B86C-E102315125F5Q34071695-7B33B24B-E4BE-4851-82A7-86DD882727CBQ35153864-53EE17A2-0C5D-4371-BA33-F08021C69C94Q35350228-DD78B265-5594-4300-83A2-738AD84BF667Q35474479-D72F45C0-045E-4A54-9212-D72B4180F039Q35623800-8C6CCF65-A3B0-4C0A-AE84-33E743879B01Q36075255-E8B814C2-1374-4E20-A871-E35051C5496AQ36627182-6AC3976F-4FFF-4204-9E2A-B9D4336C6168Q37228450-F9BADCE5-193F-4EE0-8264-78AA68355C6CQ37400530-123A11F6-BE92-4533-AF60-FD0AE480FD7EQ37612613-FEAC1DF1-637F-4250-8D4D-F2A85D4369E9Q37690308-9B955164-6ECC-4B1C-9823-CFC04A2D7E51Q37952006-91A9AB5B-5A5D-4E23-B33C-82FF9358F339Q38696795-0B5F19D7-DAF8-4FFE-A1F7-E44C9F07B0E8Q43489162-53CCC58C-E3EF-43F6-90D4-E8022C3CB297Q46588877-49D04215-A344-4780-B8D4-4C86AF24AF00Q51063025-35FBC9E7-CA7F-4632-97E9-3B2B36D71D2AQ55561332-4905C6B3-BFDC-42CD-BBCE-05A74314B984Q56888917-5179C5D9-3F84-445E-BD74-7D0C4A957EED
P2860
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
@en
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
@nl
type
label
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
@en
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
@nl
prefLabel
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
@en
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells
@en
P2093
Eugene W Gerner
Natalia A Ignatenko
Rebecca S Henkhaus
P2860
P304
P356
10.1515/BC.2008.087
P577
2008-06-01T00:00:00Z